PR Newswire
PARIS, Aug. 3, 2021 /PRNewswire/ — Sequans Communications S.A. (NYSE: SQNS), a leading developer and provider of 5G/4G chips and modules, today announced financial results for the second quarter ended June 30, 2021.
|
|
||||||
|
(in US$ millions, except share and per share data) |
|
Q1 2021 |
Q2 2020 |
|||
|
Revenue |
|
$12.3 |
$12.2 |
|||
|
Gross profit |
|
6.2 |
5.9 |
|||
|
Gross margin (%) |
|
|
|
|
|
|
|
Operating loss |
|
(5.8) |
(5.6) |
|||
|
Net loss |
|
(11.4) |
(19.0) |
|||
|
Diluted earnings per ADS |
|
($0.33) |
($0.70) |
|||
|
Non-IFRS diluted earnings per ADS (1) |
|
($0.15) |
($0.28) |
|||
|
Weighted average number of diluted ADS |
|
34,664,779 |
27,150,562 |
|||
|
(1) See Use of Non-IFRS/non-GAAP Financial Measures disclosure on page 3 |
“Massive IoT was the primary driver of growth in the second quarter, increasing 14% sequentially and 120% year-over-year,” said Georges Karam, CEO of Sequans. “Notably, we achieved this growth despite order fulfillment delays brought on by supply chain challenges that are impacting industries across the globe and that limited our overall growth in the quarter. Excluding revenue related to the Verizon Jetpack, revenue would have increased 14% sequentially and 88% year-over-year(1). The increase in our Broadband CBRS business and a new deal for Vertical applications also contributed to growth in the quarter. The significant progress we are making in Massive IoT and CBRS, and the growing relationships with our channel partners, positions Sequans for continued leadership in cellular solutions for Massive and Broadband IoT.”
“Our business pipeline is well over $600 million, with the design win portion increasing by 18% to $280 million since last quarter,” continued Mr. Karam. ” We are now working on nearly 100 design-win projects, with over 40 projects now in the production phase, primarily in Massive IoT applications along with several Broadband IoT products. The remaining 60 design-wins are advancing to revenue generation as customer projects move to manufacturing and 15 of them have placed pre-production and production orders in the second quarter.”
Mr. Karam concluded, “Thus far we have been able to support new customers in our pipeline with allotments of chips or modules needed to support their full production ramp, despite the overall demand for materials exceeding the available supply. Importantly, given the robust demand we are experiencing, we believe our overall growth trajectory and the investment thesis for our business remain intact, and we expect to achieve our medium and longer-term growth objectives as industry-wide supply challenges subside.”
Q3 2021 Outlook
The following statement is based on management’s current assumptions and expectations and assumes no increase in the severity or duration of the COVID-19 pandemic. This statement is forward-looking and actual results may differ materially.
While customer demand would allow for sequential revenue growth, given the increasing impact of the continued supply chain constraints for materials on the Company’s ability to ship orders, management is unable to provide guidance for the quarter ending September 30, 2021.
|
(1) Revenues from the Verizon Jetpack were $5.4 million in the second quarter of 2020 and $1.1 million in the first quarter of 2021. There were no revenues from the Verizon Jetpack in the second quarter of 2021. |
Second Quarter 2021 Financial and Operational Results Summary
Revenue for the second quarter was $12.9 million, an increase of 4.4% compared to the first quarter of 2021 and an increase of 5.1% compared to the second quarter of 2020. The increase from the first quarter was primarily due to increased Massive IoT revenues as well as higher Vertical services revenue, partially offset by continued supply chain constraints for materials and the absence of portable router sales.
Gross profit for the second quarter of 2021 was $7.3 million, an increase from the first quarter of $6.2 million and an increase from the prior year second quarter of $5.9 million. Gross margin for the second quarter of 2021 was 56.6% compared to 50.1% in the first quarter of 2021 and 48.3% in the second quarter of 2020. The sequential improvement in gross margin was primarily due to a shift in revenue mix with increased service revenue.
Operating loss was $3.4 million compared to $5.8 million in the first quarter of 2021 and $5.6 million in the second quarter of 2020. The sequential improvement in operating loss was primarily due to a higher gross profit margin on increased sales while operating expenses in the second quarter of 2021 benefited from a one-time net reduction in R&D expense of approximately $1.2 million as a result of an R&D grant recognized in the quarter.
Net loss was $1.3 million, or ($0.04) per diluted ADS, compared to $11.4 million, or ($0.33) per ADS, in the first quarter of 2021 and $19.0 million, or ($0.70) per ADS, in the second quarter of 2020. Net loss in the second quarter of 2021 includes the benefit of the reversal of a non-cash charge related to the fair value of an embedded derivative associated with the Company’s convertible notes that were paid off during the second quarter, partially offset by a foreign exchange loss primarily related to the revaluation of euro liabilities in the quarter.
Non-IFRS Net loss and diluted loss per ADS: Excluding the non-cash stock-based compensation, the non-cash impact of the fair-value and effective interest adjustments related to the convertible debt with embedded derivatives and other financings, the non-cash impact of convertible debt amendments, and deferred tax benefit or expense related to the convertible debt and other financings, non-IFRS net loss was $5.6 million, or ($0.15) per ADS, compared to $5.1 million, or ($0.15) per ADS in the first quarter of 2021, and $7.5 million, or ($0.28) per ADS, in the second quarter of 2020.
Cash
: Cash, cash equivalents and short-term deposits at June 30, 2021 totaled $30.3 million compared to $18.5 million at December 31, 2020.
Conference Call and Webcast
Sequans plans to conduct a teleconference and live webcast to discuss the financial results for the second quarter of 2021 today, August 3, 2021 at 8:00 a.m. ET /14:00 CET. To participate in the live call, analysts and investors should dial 877-407-0792 or +1 201-689-8263 if outside the U.S. When prompted, provide the event title or access code: 13720879. A live and archived webcast of the call will be available from the Investors section of the Sequans website at www.sequans.com/investors/. An audio replay of the conference call will be available until August 17, 2021 by dialing toll free 844-512-2921 or +1 412-317-6671 from outside the U.S., using the following access code:13720879.
Forward Looking Statements
This press release contains projections and other forward-looking statements regarding future events or our future financial performance and potential financing sources. All statements other than present and historical facts and conditions contained in this release, including any statements regarding future results of operations and financial positions, business strategy and plans, expectations for Massive IoT and portable router sales, the impact of the Covid-19 on our supply chain and on customer demand, the impact of component shortages and manufacturing capacity, our ability to convert our pipeline to revenue and our objectives for future operations, are forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These statements are only predictions and reflect our current beliefs and expectations with respect to future events and are based on assumptions and subject to risk and uncertainties and subject to change at any time. We undertake no obligation to update the information made in this release in the event facts or circumstances subsequently change after the date of this press release. We operate in a very competitive and rapidly changing environment. New risks emerge from time to time. Given these risks and uncertainties, you should not rely on or place undue reliance on these forward-looking statements. Actual events or results may differ materially from those contained in the projections or forward-looking statements. In addition to the risk factors contained in our Form 20-F for the fiscal year ended December 31, 2020, some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: (i) the contraction or lack of growth of markets in which we compete and in which our products are sold, (ii) unexpected increases in our expenses, including manufacturing expenses, (iii) our inability to adjust spending quickly enough to offset any unexpected revenue shortfall, (iv) delays or cancellations in spending by our customers, (v) unexpected average selling price reductions, (vi) the significant fluctuation to which our quarterly revenue and operating results are subject due to cyclicality in the wireless communications industry and transitions to new process technologies, (vii) our inability to anticipate the future market demands and future needs of our customers, (viii) our inability to achieve new design wins or for design wins to result in shipments of our products at levels and in the timeframes we currently expect, (ix) our inability to enter into and execute on strategic alliances, (x) our ability to meet performance milestones under strategic license agreements, (xi) the impact of natural disasters on our sourcing operations and supply chain, (xii) the impact of Covid-19 on the ability to operate our business and research, production of our products or demand for our products by customers whose supply chain is impacted or whose operations have been impacted by government shelter-in-place or similar orders, (xiii) our ability to raise debt and equity financing, and (xv) other factors detailed in documents we file from time to time with the Securities and Exchange Commission.
Use of Non-IFRS/non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements prepared in accordance with IFRS, we disclose certain non-IFRS, or non-GAAP, financial measures. These measures exclude the non-cash stock-based compensation and the non-cash impacts of convertible debt amendments, conversions and repayments, effective interest adjustments related to the convertible debt with embedded derivatives and other financings; and deferred tax benefit or expense related to the convertible debt and other financings. We believe that these measures can be useful to facilitate comparisons among different companies. These non-GAAP measures have limitations in that the non-GAAP measures we use may not be directly comparable to those reported by other companies. We seek to compensate for this limitation by providing a reconciliation of the non-GAAP financial measures to the most directly comparable IFRS measures in the table attached to this press release.
About Sequans Communications
Sequans Communications S.A. (NYSE: SQNS) is a leading developer and provider of 5G and 4G chips and modules for IoT devices. For 5G/4G massive IoT applications, Sequans provides a comprehensive product portfolio based on its flagship Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring industry-leading low power consumption, a large set of integrated functionalities, and global deployment capability. For 5G/4G broadband and critical IoT applications, Sequans offers a product portfolio based on its Cassiopeia 4G Cat 4/Cat 6 and high-end Taurus 5G chip platforms, optimized for low-cost residential, enterprise, and industrial applications. Founded in 2003, Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Finland, Taiwan, South Korea, and China.
Visit Sequans online at www.sequans.com; www.facebook.com/sequans; www.twitter.com/sequans
Media Relations: Kimberly Tassin, +1.425.736.0569, [email protected]
Investor Relations: Kimberly Rogers, +1 385.831-7337, [email protected]
Condensed financial tables follow
|
|
||||
|
|
||||
|
|
||||
|
|
|
|
|
|
|
|
||||
|
Product revenue |
7,393 |
8,548 |
8,774 |
|
|
Other revenue |
5,464 |
3,773 |
3,457 |
|
|
|
|
|
|
|
|
|
– |
– |
||
|
Cost of product revenue |
5,133 |
5,691 |
5,884 |
|
|
Cost of other revenue |
449 |
452 |
440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
– |
– |
||
|
Research and development |
5,848 |
7,254 |
7,512 |
|
|
Sales and marketing |
2,297 |
2,294 |
1,871 |
|
|
General and administrative |
2,507 |
2,460 |
2,082 |
|
|
– |
– |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
– |
– |
||
|
Interest income (expense), net |
(3,411) |
(2,711) |
(3,717) |
|
|
Change in fair value of convertible debt derivative |
1,408 |
(4,090) |
(9,141) |
|
|
Impact of debt reimbursement |
5,177 |
– |
– |
|
|
Foreign exchange gain (loss) |
(964) |
1,358 |
(505) |
|
|
|
|
|
|
|
|
|
150 |
147 |
34 |
|
|
|
|
|
|
|
|
|
– |
– |
||
|
Shareholders of the parent |
(1,317) |
(11,420) |
(18,955) |
|
|
Minority interests |
– |
– |
– |
|
|
Basic loss per ADS |
($0.04) |
($0.33) |
($0.70) |
|
|
Diluted loss per ADS |
($0.04) |
($0.33) |
($0.70) |
|
|
Weighted average number of ADS used for computing: |
– |
– |
||
|
— Basic |
37,118,845 |
34,664,779 |
27,150,562 |
|
|
— Diluted |
37,118,845 |
34,664,779 |
27,150,562 |
|
|
|
|||
|
|
|||
|
|
|||
|
|
|
|
|
|
|
|||
|
Product revenue |
15,941 |
14,275 |
|
|
Other revenue |
9,237 |
6,728 |
|
|
|
|
|
|
|
|
|||
|
Cost of product revenue |
10,824 |
9,781 |
|
|
Cost of other revenue |
901 |
813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Research and development |
13,102 |
14,933 |
|
|
Sales and marketing |
4,591 |
4,135 |
|
|
General and administrative |
4,967 |
4,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Interest income (expense), net |
(6,122) |
(7,208) |
|
|
Change in fair value of convertible debt derivative |
(2,682) |
(14,762) |
|
|
Impact of debt reimbursement |
5,177 |
1,399 |
|
|
Foreign exchange gain (loss) |
394 |
170 |
|
|
|
|
|
|
|
|
297 |
477 |
|
|
|
|
|
|
|
|
– |
||
|
Shareholders of the parent |
(12,737) |
(34,224) |
|
|
Minority interests |
– |
– |
|
|
Basic loss per ADS |
($0.35) |
(1.34) |
|
|
Diluted loss per ADS |
($0.35) |
(1.34) |
|
|
Weighted average number of ADS used for computing: |
|||
|
— Basic |
35,894,642 |
25,502.105 |
|
|
— Diluted |
35,894,642 |
25,502.105 |
|
|
|
||||||||
|
|
||||||||
|
|
|
|||||||
|
|
|
|
||||||
|
|
||||||||
|
|
||||||||
|
Property, plant and equipment |
$ |
8,103 |
$ |
9,187 |
||||
|
Intangible assets |
31,535 |
25,312 |
||||||
|
Deposits and other receivables |
3,414 |
588 |
||||||
|
Other non-current financial assets |
374 |
386 |
||||||
|
|
43,426 |
35,473 |
||||||
|
|
||||||||
|
Inventories |
5,206 |
6,225 |
||||||
|
Trade receivables |
7,433 |
17,277 |
||||||
|
Contract assets |
806 |
371 |
||||||
|
Prepaid expenses |
2,712 |
962 |
||||||
|
Other receivables |
6,609 |
3,264 |
||||||
|
Research tax credit receivable |
6,724 |
5,110 |
||||||
|
Short-term deposits |
26,500 |
10,900 |
||||||
|
Cash and cash equivalents |
3,783 |
7,574 |
||||||
|
|
59,773 |
51,683 |
||||||
|
|
|
|
|
|
||||
|
|
||||||||
|
|
||||||||
|
Issued capital, euro 0.02 nominal value, 149,475,334 shares authorized, issued and outstanding at June 30, 2021 (133,934,090 shares at December 31, 2020) |
$ |
3,642 |
$ |
3,269 |
||||
|
Share premium |
298,434 |
276,560 |
||||||
|
Other capital reserves |
54,315 |
46,677 |
||||||
|
Accumulated deficit |
(375,946) |
(363,209) |
||||||
|
Other components of equity |
(414) |
(423) |
||||||
|
|
(19,969) |
(37,126) |
||||||
|
|
||||||||
|
Government grant advances, loans and other liabilities |
11,364 |
11,203 |
||||||
|
Venture debt |
— |
2,172 |
||||||
|
Convertible debt |
32,912 |
26,074 |
||||||
|
Convertible debt embedded derivative |
16,611 |
12,395 |
||||||
|
Lease liabilities |
3,852 |
4,762 |
||||||
|
Trade payables |
890 |
851 |
||||||
|
Provisions |
2,241 |
1,874 |
||||||
|
Deferred tax liabilities |
20 |
19 |
||||||
|
Contract liabilities |
254 |
2,397 |
||||||
|
|
68,144 |
61,747 |
||||||
|
|
||||||||
|
Trade payables |
16,205 |
15,701 |
||||||
|
Interest-bearing receivables financing |
10,755 |
14,228 |
||||||
|
Venture debt |
— |
6,104 |
||||||
|
Lease liabilities |
1,213 |
1,014 |
||||||
|
Government grant advances and loans |
6,658 |
3,867 |
||||||
|
Contract liabilities |
9,266 |
13,145 |
||||||
|
Other current liabilities and provisions |
10,927 |
8,476 |
||||||
|
|
55,024 |
62,535 |
||||||
|
|
|
|
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
|
|
||
|
|
||||
|
Loss before income taxes |
|
|
||
|
Non-cash adjustment to reconcile income before tax to net cash from (used in) operating activities |
||||
|
Depreciation and impairment of property, plant and equipment |
1,963 |
1,934 |
||
|
Amortization and impairment of intangible assets |
3,721 |
2,624 |
||
|
Share-based payment expense |
2,252 |
1,292 |
||
|
Increase in provisions |
253 |
(40) |
||
|
Interest expense, net |
6,122 |
7,274 |
||
|
Other financial expenses |
– |
– |
||
|
Change in the fair value of convertible debt embedded derivative |
2,682 |
14,762 |
||
|
Impact of debt reimbursement |
(5,177) |
– |
||
|
Convertible debt amendment |
– |
(1,399) |
||
|
Foreign exchange loss (gain) |
(441) |
127 |
||
|
Loss (Gain) on disposal of property, plant and equipment |
7 |
– |
||
|
Bad debt expense |
– |
18 |
||
|
Working capital adjustments |
– |
|||
|
Decrease (Increase) in trade receivables and other receivables |
7,432 |
(3,709) |
||
|
Decrease in inventories |
1,019 |
802 |
||
|
Decrease (Increase) in research tax credit receivable |
(635) |
1,680 |
||
|
Increase in trade payables and other liabilities |
6,891 |
4,310 |
||
|
Decrease in contract liabilities |
(7,437) |
(5,835) |
||
|
Decrease in deferred revenue |
– |
– |
||
|
Increase (Decrease) in government grant advances |
561 |
919 |
||
|
Income tax paid |
(270) |
(180) |
||
|
|
|
|
||
|
|
||||
|
Purchase of intangible assets and property, plant and equipment |
(6,242) |
(2,845) |
||
|
Capitalized development expenditures |
(9,535) |
(3,048) |
||
|
Purchase of financial assets |
(2,814) |
(27) |
||
|
Decrease of short-term deposit |
(15,600) |
(17,900) |
||
|
Interest received |
24 |
20 |
||
|
|
|
|
||
|
|
||||
|
Proceeds from issue of warrants, exercise of stock options/warrants |
96 |
32 |
||
|
Public equity offering proceeds, net of transaction costs paid |
9,894 |
29,503 |
||
|
Proceeds from issuing of warrants, net of transaction costs paid |
– |
– |
||
|
Proceeds (Repayment of) from interest-bearing receivables financing |
(3,341) |
5,572 |
||
|
Proceeds from government loans, net of transaction cost |
– |
5,392 |
||
|
Proceeds from interest-bearing research project financing |
– |
405 |
||
|
Proceeds from convertible debt, net of transaction cost |
39,647 |
– |
||
|
Proceeds from research tax credit financing |
– |
|||
|
Repayment of venture debt |
(8,042) |
(2,449) |
||
|
Repayment of government loans |
(240) |
– |
||
|
Repayment of interest-bearing research project financing |
(363) |
– |
||
|
Repayment of finance lease liabilities |
(550) |
(786) |
||
|
Repayment of convertible debt |
(8,750) |
– |
||
|
Interest paid |
(4,480) |
(1,215) |
||
|
|
|
|
||
|
Net increase (decrease) in cash and cash equivalents |
(3,793) |
3,486 |
||
|
Net foreign exchange difference |
2 |
(3) |
||
|
Cash and cash equivalents at January 1 |
7,574 |
14,098 |
||
|
|
|
|
||
|
|
|||||||||||||
|
|
|||||||||||||
|
|
|
||||||||||||
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||
|
|
|||||||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
1,092 |
1,160 |
625 |
||||||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
(1,408) |
4,090 |
9,141 |
||||||||||
|
Non-cash interest on convertible debt and other financing (2) |
1,187 |
1,085 |
1,671 |
||||||||||
|
Impact of debt reimbursement |
(5,177) |
— |
— |
||||||||||
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
||||||||||
|
|
|||||||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
|
|
|
||||||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
|
|
|
||||||||||
|
Non-cash interest on convertible debt and other financing (2) |
|
|
|
||||||||||
|
Impact of debt reimbursement |
|
|
|
||||||||||
|
|
|
|
|
||||||||||
|
|
|
|
|
||||||||||
|
|
|||||||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
|
|
|
||||||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
|
|
|
||||||||||
|
Non-cash interest on convertible debt and other financing (2) |
|
|
|
||||||||||
|
Impact of debt reimbursement |
|
|
|
||||||||||
|
|
|
|
|
||||||||||
|
(1) Included in the IFRS loss as follows: |
|||||||||||||
|
Cost of product revenue |
$ |
14 |
$ |
15 |
$ |
4 |
|||||||
|
Research and development |
513 |
554 |
266 |
||||||||||
|
Sales and marketing |
206 |
217 |
111 |
||||||||||
|
General and administrative |
359 |
374 |
244 |
||||||||||
|
(2) Related to the difference between contractual and effective interest rates |
|||||||||||||
|
|
|||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|
||||||||
|
|
|
|
|
|
|||||
|
|
|||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
2,252 |
1,292 |
|||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
2,682 |
14,762 |
|||||||
|
Non-cash interest on convertible debt and other financing (2) |
2,272 |
2,965 |
|||||||
|
Non-cash impact of deferred tax income (loss) |
— |
398 |
|||||||
|
Impact of debt reimbursement |
(5,177) |
— |
|||||||
|
Non-cash impact of convertible debt amendment |
— |
(1,399) |
|||||||
|
|
|
|
|
||||||
|
IFRS basic loss per ADS as reported |
|
($1.34) |
|||||||
|
|
|||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
|
|
|||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
|
|
|||||||
|
Non-cash interest on convertible debt and other financing (2) |
|
|
|||||||
|
Non-cash impact of deferred tax income (loss) |
|
|
|||||||
|
Impact of debt reimbursement |
|
|
|||||||
|
Non-cash impact of convertible debt amendment |
|
|
|||||||
|
|
|
|
|||||||
|
IFRS diluted loss per ADS |
|
|
|||||||
|
|
|||||||||
|
Non-cash stock-based compensation expense according to IFRS 2 (1) |
|
|
|||||||
|
Non-cash change in the fair value of convertible debt embedded derivative |
|
|
|||||||
|
Non-cash interest on convertible debt and other financing (2) |
|
|
|||||||
|
Non-cash impact of deferred tax income (loss) |
|
|
|||||||
|
Impact of debt reimbursement |
|
|
|||||||
|
Non-cash impact of convertible debt amendment |
|
|
|||||||
|
|
|
|
|||||||
|
(1) Included in the IFRS loss as follows: |
|||||||||
|
Cost of product revenue |
$ |
30 |
$ |
9 |
|||||
|
Research and development |
1,067 |
538 |
|||||||
|
Sales and marketing |
423 |
235 |
|||||||
|
General and administrative |
732 |
510 |
|||||||
|
(2) Related to the difference between contractual and effective interest rates |
|||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/sequans-communications-announces-second-quarter-2021-financial-results-301346786.html
SOURCE Sequans Communications
